Post

New research · Ophthalmology
The Journal of international medical research · 4d
Case reportThe Journal of international medical research · 2026

Probable linezolid-associated bilateral toxic optic neuropathy after prolonged therapy: A case report.

Si-Yu Chang, Chun-Xia Zhang, Yue Cong, Xu Li
Read paper
OphthalmologyCase report

Long-term unsupervised linezolid use linked to optic nerve damage in both eyes.

Probable linezolid-associated bilateral toxic optic neuropathy after prolonged therapy: A case report.

Si-Yu Chang … Xu Li
The Journal of international medical research · 2026
Background

A woman in her 30s was administered linezolid treatment for pneumonia.

9
Results
9
months
self-treatment lasted this long before eye damage appeared
More results

Visual field testing indicated the presence of central scotomas in both eyes.

Visual evoked potentials testing showed reduced amplitudes in both eyes.

After discontinuing linezolid, the patient's visual function gradually improved.

“
Conclusion

This case suggests that close monitoring of visual function and neurological symptoms in patients receiving linezolid treatment is crucial, and early identification of relevant abnormalities and timely discontinuation of the drug can effectively improve patient prognosis.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving